OPEN END TURBO PUT WARRANT - AMGEN | Real-time Boerse Frankfurt Warrants 14:55:24 10/06/2024 BST | ||
| 1.21 EUR | +2.54% |
|
| 3 months | -21.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 10/06/24 | 1.21 | +2.54% |
| 07/06/24 | 1.18 | +0.85% |
| 06/06/24 | 1.17 | +1.74% |
| 05/06/24 | 1.15 | -0.86% |
| 04/06/24 | 1.16 | -1.69% |
Real-time Boerse Frankfurt Warrants
Last update June 10, 2024 at 02:55 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM0JA3 |
| ISIN | DE000UM0JA31 |
| Date issued | 10/01/2024 |
| Strike | 434.1 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.63 € |
|---|---|
| Lowest since issue | 1.03 € |
| Spread | 0.02 € |
| Spread % | 1.61% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
